Insider · CIK 0001569334
Pete O'Heeron
Files at LBSR (LIBERTY STAR URANIUM & METALS CORP.), FBLG (FibroBiologics, Inc.). First filing Mar 4, 2025, latest Sep 30, 2026.
Pete O'Heeron files SEC Form 4 as CEO, director, 10% owner and CFO at LBSR (LIBERTY STAR URANIUM & METALS CORP.), and also at FBLG (FibroBiologics, Inc.). Since Mar 4, 2025, Pete O'Heeron has reported 4 open-market buys worth $537k and 0 open-market sells worth $0, the latest filed on Sep 30, 2026.
A track record needs three past buys with six months of prices behind them; Pete O'Heeron has 0, so none is measured yet.
The newest scored trade: bought $3,910 of LBSR on Sep 28, 2026, filed Sep 30, 2026, scored 30 (weak). In the last 12 months: 2 buys worth $23k and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
LBSR: LIBERTY STAR URANIUM & METALS CORP.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
FBLG: FibroBiologics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | LBSRbuy LIBERTY STAR URANIUM & METALS CORP. | $3,910 171,482 shares | - | - | |
| 43Moderate | FibroBiologics, Inc. | $20k 51,500 shares | +1% | +87% from low-70% from high | |
| 66Notable | LBSRbuy LIBERTY STAR URANIUM & METALS CORP. | $237k 3,190,718 shares | - | 0% from low-71% from high | |
| 59Moderate | LIBERTY STAR URANIUM & METALS CORP. | $277k 3,080,670 shares | - | - |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Common Stock | +171,482 | $0.02 | $3,910 | 171,482 | 13 d ago |
| Sep 28, 2026 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Warrantsderivative | +85,741 | $0.02 | $1,955 | 85,741 | 13 d ago |
| May 4, 2026 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +92,410 | $0.00 | $0 | 92,410 | May 4, 2026 |
| Mar 2, 2026 | FBLG FibroBiologics, Inc. | POpen-market purchase Common Stock | +17,428 | $0.35 | $6,152 | 5,924,075 | Mar 4, 2026 |
| Mar 3, 2026 | FBLG FibroBiologics, Inc. | POpen-market purchase Common Stock | +18,200 | $0.41 | $7,373 | 5,942,275 | Mar 4, 2026 |
| Mar 4, 2026 | FBLG FibroBiologics, Inc. | POpen-market purchase Common Stock | +15,872 | $0.38 | $6,006 | 5,958,147 | Mar 4, 2026 |
| Aug 20, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | AGrant or award Non Qualified stock Optionsderivative | +1,000,000 | $0.07 | $70k | 1,000,000 | Aug 22, 2025 |
| May 27, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Common Stock | +3,190,718 | $0.07 | $237k | 3,190,718 | May 27, 2025 |
| May 27, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Warrantsderivative | +1,595,359 | $0.07 | $118k | 1,595,359 | May 27, 2025 |
| Mar 26, 2025 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +453,000 | $0.00 | $0 | 453,000 | Mar 28, 2025 |
| Mar 4, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Common Stock | +3,080,670 | $0.09 | $277k | 3,080,670 | Mar 4, 2025 |
| Mar 4, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | POpen-market purchase Warrantsderivative | +1,540,335 | $0.09 | $139k | 1,540,335 | Mar 4, 2025 |
| Jan 29, 2025 | LBSR LIBERTY STAR URANIUM & METALS CORP. | AGrant or award Non Qualified stock Optionsderivative | +583,333 | $0.12 | $70k | 583,333 | Jan 31, 2025 |
| Dec 27, 2024 | FBLG FibroBiologics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +406,339 | $0.00 | $0 | 406,339 | Dec 30, 2024 |
| Dec 9, 2024 | FBLG FibroBiologics, Inc. | GGift Common Stock | -100,000 | $0.00 | $0 | 5,906,647 | Dec 9, 2024 |
| Dec 3, 2024 | FBLG FibroBiologics, Inc. | GGift Common Stock | -50,000 | $0.00 | $0 | 6,006,647 | Dec 5, 2024 |
Questions about Pete O'Heeron
Answered from the filings on this page, as of the latest one.
Is Pete O'Heeron buying or selling?
In the last 12 months Pete O'Heeron reported 2 open-market buys worth $23k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $3,910 of LBSR on Sep 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Pete O'Heeron's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pete O'Heeron has 0.
Where does Pete O'Heeron file Form 4?
Pete O'Heeron has filed Form 4 at LBSR (LIBERTY STAR URANIUM & METALS CORP.) as COB, SEC & TREAS; FBLG (FibroBiologics, Inc.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.